What Is Transurethral Resection of Bladder Tumor (TURBT)? If you have bladder cancer or suspected bladder cancer, your doctor has probably told you that you need a transurethral resection of the ...
What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete responseToronto, Ontario--(Newsfile Corp. - ...
Researchers have developed a microrobotic drug delivery system that is simple and biocompatible, using it successfully in ...
Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
3don MSN
Can colorblindness lead to worse outcomes for bladder cancer patients? A new study suggests so
The earliest symptoms of bladder cancer may go unnoticed by patients with colorblindness or similar color vision deficiencies ...
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...
Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...
The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...
"With its potential for screening, recurrence monitoring, treatment guidance, and prognosis prediction, utDNA is poised to transform bladder cancer management and personalize patient care." — Liang ...
Live Science on MSN
Color blindness linked to lower bladder cancer survival, early study hints
People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed later, a study suggests.
A financing arrangement between biotech billionaire Dr. Patrick Soon-Shiong and ImmunityBio Inc. helped “bridge the gap” to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results